Insulet Corporation (PODD) is a publicly traded Healthcare sector company. As of October 9, 2026, PODD trades at $135.95 with a market cap of $9.32B and a P/E ratio of 25.42. PODD moved +1.66% today. Year to date, PODD is -52.47%; over the trailing twelve months it is -57.38%. Its 52-week range spans $126.40 to $354.88. Analyst consensus is buy with an average price target of $164.43. Rallies surfaces PODD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for PODD, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $135.95 |
| Market Cap | $9.32B |
| P/E Ratio | 25.42 |
| EPS | $5.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $354.88 |
| 52-Week Low | $126.40 |
| Volume | 126.98K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.05B |
| Net Income | $375.30M |
| Gross Margin | 71.08% |
18 analysts cover PODD: 0 strong buy, 9 buy, 9 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $164.43.